Quick Answer
Imunon, Inc. reported Total Revenue of $500.0 thousand for fiscal year 2022.
Imunon, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2022 | $500.0K | +0.0% |
| 2021 | $500.0K | +0.0% |
| 2020 | $500.0K | +0.0% |
| 2019 | $500.0K | +0.0% |
| 2018 | $500.0K | +0.0% |
| 2017 | $500.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $125.0K | +0.0% | +0.0% |
| June 30, 2022 | $125.0K | +0.0% | +0.0% |
| March 31, 2022 | $125.0K | +0.0% | +0.0% |
| September 30, 2021 | $125.0K | +0.0% | +0.0% |
| June 30, 2021 | $125.0K | +0.0% | +0.0% |
| March 31, 2021 | $125.0K | +0.0% | +0.0% |
| September 30, 2020 | $125.0K | +0.0% | +0.0% |
| June 30, 2020 | $125.0K | +0.0% | +0.0% |
- Imunon, Inc. showed an increase of +0.0% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2022 period, Imunon, Inc.’s total revenue has grown by 0.0% (from $500.0 thousand to $500.0 thousand).
- The most recent figure is from Imunon, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: